Results 191 to 200 of about 16,374 (258)

Change in healthcare costs in Europe 2018-2023 (data report). [PDF]

Front Public Health
Wozniak-Holecka J, Smółka J, Sobczyk K, Holecki T.   +3 more
europepmc   +1 more source

[The problems of introducing compulsory medical insurance in Russia].

Terapevticheskii arkhiv, 1994
openaire   +1 more source

CONSISTENCY FEATURES OF COMPULSORY AND VOLUNTARY INSURANCE IN SYSTEM OF MEDICAL INSURANCE FINANCIAL PROVISION

Scientific Notes of Ostroh Academy National University, "Economics" Series, 2019
openaire   +2 more sources

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Mental health stigma and legal responses to defendants with mental health conditions in Bulgaria, Japan, and Norway. [PDF]

Front Psychol
Gröning L, Dimitrova S, Hirano M.
europepmc   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Forgoing Healthcare and Insurance Premiums Trends: A 15-Year Population-Based Study in Geneva, Switzerland. [PDF]

Int J Public Health
Nehme M, Dumont R, Heritier H, Lamour J, Mechoullam S, De Ridder D, Guessous I.   +6 more
europepmc   +1 more source

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

Assessment of financial toxicity in patients with cancer in Slovenia. [PDF]

Support Care Cancer
Vöröš K, Skubic M, Bavdaž M, Došenović Bonča P, Perhavec A, Redek T, Zobec Logar HB, Ratoša I.   +7 more
europepmc   +1 more source

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

British Journal of Clinical Pharmacology, EarlyView.
Christina Gao, Ashley M. Hopkins, Andrew Rowland, Stephen Bacchi   +3 more
wiley   +1 more source